We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist in development for the treatment of pat...
Use this information to figure out if this company is an ideal customer for you.
510.293.8800
7575 Gateway Boulevard
Newark, 94560
51 - 200 Employees
$5M - $20M
linkedin.com/company/cymabay-therapeutics
CymaBay Therapeutics's CEO is Malu Reyes
CymaBay Therapeutics's CFO is Harish Shantharam
CymaBay Therapeutics's HQ is located at 7575 Gateway Boulevard, Newark
CymaBay Therapeutics's phone number is 510.293.8800
CymaBay Therapeutics's official website is cymabay.com
CymaBay Therapeutics's revenue is $5M - $20M
CymaBay Therapeutics has 51 - 200 employees
CymaBay Therapeutics is in the industry of: Pharmaceuticals
